Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia

Clozapine is considered the gold standard for patients with treatment-resistant schizophrenia (TRS) who have previously tried other antipsychotics at adequate doses (two or more, with at least one being atypical). However, despite optimal treatment, a subgroup of TRS patients with what is known as u...

ver descrição completa

Detalhes bibliográficos
Principais autores: Vjekoslav Peitl, Antonia Puljić, Mislav Škrobo, Sergej Nadalin, Lidija Fumić Dunkić, Dalibor Karlović
Formato: Artigo
Idioma:English
Publicado em: MDPI AG 2023-04-01
coleção:Biomedicines
Assuntos:
Acesso em linha:https://www.mdpi.com/2227-9059/11/4/1072